179 related articles for article (PubMed ID: 18707868)
1. A diagnostic model to detect silent brain metastases in patients with non-small cell lung cancer.
Na II; Lee TH; Choe DH; Cheon GJ; Kim CH; Koh JS; Baek H; Ryoo BY; Yang SH; Lee JC
Eur J Cancer; 2008 Nov; 44(16):2411-7. PubMed ID: 18707868
[TBL] [Abstract][Full Text] [Related]
2. Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma.
Bajard A; Westeel V; Dubiez A; Jacoulet P; Pernet D; Dalphin JC; Depierre A
Lung Cancer; 2004 Sep; 45(3):317-23. PubMed ID: 15301872
[TBL] [Abstract][Full Text] [Related]
3. Risk of cerebral metastases for postoperative locally advanced non-small-cell lung cancer.
Wang SY; Ye X; Ou W; Lin YB; Zhang BB; Yang H
Lung Cancer; 2009 May; 64(2):238-43. PubMed ID: 18838190
[TBL] [Abstract][Full Text] [Related]
4. Necessity of preoperative screening for brain metastasis in non-small cell lung cancer patients without lymph node metastasis.
Yohena T; Yoshino I; Kitajima M; Uehara T; Kanematsu T; Teruya T; Ikeda J; Ichinose Y
Ann Thorac Cardiovasc Surg; 2004 Dec; 10(6):347-9. PubMed ID: 15658906
[TBL] [Abstract][Full Text] [Related]
5. Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: a retrospective case-control study.
Papotti M; Kalebic T; Volante M; Chiusa L; Bacillo E; Cappia S; Lausi P; Novello S; Borasio P; Scagliotti GV
J Clin Oncol; 2006 Oct; 24(30):4818-24. PubMed ID: 17050866
[TBL] [Abstract][Full Text] [Related]
6. Imaging lung cancer.
Patz EF
Semin Oncol; 1999 Oct; 26(5 Suppl 15):21-6. PubMed ID: 10566607
[TBL] [Abstract][Full Text] [Related]
7. Non-small cell lung cancer and silent brain metastasis. Survival and prognostic factors.
Sánchez de Cos J; Sojo González MA; Montero MV; Pérez Calvo MC; Vicente MJ; Valle MH
Lung Cancer; 2009 Jan; 63(1):140-5. PubMed ID: 18556086
[TBL] [Abstract][Full Text] [Related]
8. Optimizing intracranial metastasis detection for stereotactic radiosurgery.
Engh JA; Flickinger JC; Niranjan A; Amin DV; Kondziolka DS; Lunsford LD
Stereotact Funct Neurosurg; 2007; 85(4):162-8. PubMed ID: 17259753
[TBL] [Abstract][Full Text] [Related]
9. [How can metastatic extension be assessed in the brain?].
Baleriaux D; Lemort M
Rev Mal Respir; 1992; 9 Suppl 4():R277-80. PubMed ID: 1336873
[TBL] [Abstract][Full Text] [Related]
10. [Lung cancer in women: clinical features and factors related to survival].
Sen E; Kaya A; Erol S; Savas I; Gonullu U
Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy.
Sekine I; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
Lung Cancer; 2009 Aug; 65(2):219-22. PubMed ID: 19081161
[TBL] [Abstract][Full Text] [Related]
12. Detection of brain metastases from small cell lung cancer: consequences of changing imaging techniques (CT versus MRI).
Seute T; Leffers P; ten Velde GP; Twijnstra A
Cancer; 2008 Apr; 112(8):1827-34. PubMed ID: 18311784
[TBL] [Abstract][Full Text] [Related]
13. [The correlation between the distant metastases and organ-specific symptoms in the patients with lung cancer].
Alpar S; Uçar N; Turgut A; Kiratli T; Dursun BA; Kurt B
Tuberk Toraks; 2004; 52(1):14-8. PubMed ID: 15143367
[TBL] [Abstract][Full Text] [Related]
14. Early detection of metachronous brain metastases by biannual brain MRI follow-up may provide patients with non-small cell lung cancer with more opportunities to have radiosurgery.
Nishikawa T; Ueba T; Kawashima M; Kajiwara M; Iwata R; Kato M; Miyamatsu N; Yamashita K
Clin Neurol Neurosurg; 2010 Nov; 112(9):770-4. PubMed ID: 20621414
[TBL] [Abstract][Full Text] [Related]
15. Silent radiological imaging time in patients with brain metastasis.
Mystakidou K; Boviatsis EJ; Kouyialis AT; Voumvourakis K; Kouloulias V; Kouvaris J; Vlahos L
Clin Neurol Neurosurg; 2004 Sep; 106(4):300-4. PubMed ID: 15297004
[TBL] [Abstract][Full Text] [Related]
16. S100beta as a predictor of brain metastases: brain versus cerebrovascular damage.
Vogelbaum MA; Masaryk T; Mazzone P; Mekhail T; Fazio V; McCartney S; Marchi N; Kanner A; Janigro D
Cancer; 2005 Aug; 104(4):817-24. PubMed ID: 15971200
[TBL] [Abstract][Full Text] [Related]
17. Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases.
Oh Y; Taylor S; Bekele BN; Debnam JM; Allen PK; Suki D; Sawaya R; Komaki R; Stewart DJ; Karp DD
Cancer; 2009 Jul; 115(13):2930-8. PubMed ID: 19441110
[TBL] [Abstract][Full Text] [Related]
18. Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases.
Hsiao SH; Chung CL; Chou YT; Lee HL; Lin SE; Liu HE
Lung Cancer; 2013 Nov; 82(2):319-23. PubMed ID: 24018025
[TBL] [Abstract][Full Text] [Related]
19. CT, positron emission tomography, and MRI in staging lung cancer.
Erasmus JJ; Sabloff BS
Clin Chest Med; 2008 Mar; 29(1):39-57, v. PubMed ID: 18267183
[TBL] [Abstract][Full Text] [Related]
20. Brain Imaging for Staging of Patients With Clinical Stage IA Non-small Cell Lung Cancer in the National Lung Screening Trial: Adherence With Recommendations From the Choosing Wisely Campaign.
Balekian AA; Fisher JM; Gould MK
Chest; 2016 Apr; 149(4):943-50. PubMed ID: 26356134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
